Impact of SGLT2 Inhibitors on Atrial Fibrillation Recurrence after Catheter Ablation in Type 2 Diabetes Mellitus: A Meta-Analysis of Reconstructed Kaplan-Meier Curves with Trial Sequential Analysis.

Youssef SolimanMohamed AbuelazmBasma Ehab AmerMishaal HukamdadMohamed Hatem EllabbanNada Ibrahim HendiAdel MouffokesBasel AbdelAzeemHatem Hassaballa

Published in: American journal of cardiovascular drugs : drugs, devices, and other interventions (2024)

SGLT2i are associated with a reduced risk of AF recurrence after CA in patients with T2DM. These results suggest that SGLT2i is promising in improving clinical outcomes for this population.

Keyphrases

atrial fibrillation
catheter ablation
left atrial
left atrial appendage
oral anticoagulants
direct oral anticoagulants
heart failure
percutaneous coronary intervention
study protocol
phase iii
left ventricular
type diabetes
phase ii
randomized controlled trial
open label